Skip to main content
Erschienen in: Current Cardiology Reports 2/2011

01.04.2011

Risk Scores for Predicting Outcomes in Valvular Heart Disease: How Useful?

verfasst von: Michael J. Mack

Erschienen in: Current Cardiology Reports | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Risk scoring tools have been developed from clinical databases to predict expected patient mortality from cardiac surgical procedures. The risk algorithms have been developed and validated from variables that have been demonstrated to be predictive of mortality. At least six risk models have been developed from different databases measuring outcomes of cardiac surgery. These algorithms have then been used to select very high risk patients for conventional aortic valve replacement (AVR) who would be appropriate candidates for transcatheter aortic valve implantation (TAVI). The two most common risk models used for TAVI selection are the logistic EuroSCORE (LES) and the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) algorithms. Although both models are accurate in predicting mortality in low-risk patients, the LES has been clearly demonstrated to overpredict expected mortality by a factor of three in high-risk candidates for AVR. Various factors that also impact mortality but are not included in either algorithm include liver disease, frailty, porcelain aorta, and previous radiation. Despite these shortcomings, risk algorithms are effective models for predicting risk, with the STS-PROM being more accurate in high-risk patients. Ultimately, a new risk algorithm specific for TAVI will need to be developed once sufficient databases are developed.
Literatur
1.
Zurück zum Zitat Cowper DC, Kubal JD, Maynard C, Hynes DM. A primer and comparative review of major US mortality databases. Ann Epidemiol. 2002;12:462–8.CrossRefPubMed Cowper DC, Kubal JD, Maynard C, Hynes DM. A primer and comparative review of major US mortality databases. Ann Epidemiol. 2002;12:462–8.CrossRefPubMed
2.
Zurück zum Zitat Hannan EL, Racz MJ, Jollis JG, Peterson ED. Using Medicare claims data to assess provider quality for CABG surgery: does it work well enough? Health Serv Res. 1997;31:659–78.PubMed Hannan EL, Racz MJ, Jollis JG, Peterson ED. Using Medicare claims data to assess provider quality for CABG surgery: does it work well enough? Health Serv Res. 1997;31:659–78.PubMed
3.
Zurück zum Zitat Hannan EL, Kilburn H Jr, Lindsey ML, Lewis R. Clinical versus administrative data bases for CABG surgery. Does it matter? Med Care. 1992;30:892–907.CrossRefPubMed Hannan EL, Kilburn H Jr, Lindsey ML, Lewis R. Clinical versus administrative data bases for CABG surgery. Does it matter? Med Care. 1992;30:892–907.CrossRefPubMed
4.
Zurück zum Zitat Mack MJ, Herbert M, Prince S, Dewey TM,Magee MJ, Edgerton JR. Does reporting of coronary artery bypass grafting from administrative databases accurately reflect actual clinical outcomes? J Thorac Cardiovasc Surg. 2005;129:1309–17.CrossRefPubMed Mack MJ, Herbert M, Prince S, Dewey TM,Magee MJ, Edgerton JR. Does reporting of coronary artery bypass grafting from administrative databases accurately reflect actual clinical outcomes? J Thorac Cardiovasc Surg. 2005;129:1309–17.CrossRefPubMed
5.
Zurück zum Zitat Shahian DM, Silverstein T, Lovett AF, Wolf RE, Normand SL. Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation. 2007;115:1518–27.CrossRefPubMed Shahian DM, Silverstein T, Lovett AF, Wolf RE, Normand SL. Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation. 2007;115:1518–27.CrossRefPubMed
6.
Zurück zum Zitat Geissler HJ, Hölzl P, Marohl S, Kuhn-Régnier F, Mehlhorn U, Südkamp M, et al. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg. 2000;17:400–6CrossRefPubMed Geissler HJ, Hölzl P, Marohl S, Kuhn-Régnier F, Mehlhorn U, Südkamp M, et al. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg. 2000;17:400–6CrossRefPubMed
7.
Zurück zum Zitat Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L. Risk factors and outcomes in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816–22.CrossRefPubMed Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L. Risk factors and outcomes in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816–22.CrossRefPubMed
8.
Zurück zum Zitat Roques F, Nashef SA, Michel P, EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis. 2001;10:572–7.PubMed Roques F, Nashef SA, Michel P, EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis. 2001;10:572–7.PubMed
9.
Zurück zum Zitat Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation 2005;112:224–31.CrossRefPubMed Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation 2005;112:224–31.CrossRefPubMed
10.
Zurück zum Zitat Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001;37:885–92.CrossRefPubMed Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001;37:885–92.CrossRefPubMed
11.
Zurück zum Zitat Hannan EL, Wu C, Bennett EV, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 2007;83:921–9.CrossRefPubMed Hannan EL, Wu C, Bennett EV, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 2007;83:921–9.CrossRefPubMed
12.
Zurück zum Zitat Jin R, Grunkemeier GL, Starr A. Validation and refinement of mortality risk models for heart valve surgery. Ann Thorac Surg 2005;80:471–9.CrossRefPubMed Jin R, Grunkemeier GL, Starr A. Validation and refinement of mortality risk models for heart valve surgery. Ann Thorac Surg 2005;80:471–9.CrossRefPubMed
13.
Zurück zum Zitat Kuduvalli M, Grayson AD, Au J, Grotte G, Bridgewater B, Fabri BM. A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement. Eur J Cardiothorac Surg 2007;31:607–13.CrossRefPubMed Kuduvalli M, Grayson AD, Au J, Grotte G, Bridgewater B, Fabri BM. A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement. Eur J Cardiothorac Surg 2007;31:607–13.CrossRefPubMed
14.
Zurück zum Zitat Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 2004;77:1966–77.CrossRefPubMed Nowicki ER, Birkmeyer NJ, Weintraub RW, et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 2004;77:1966–77.CrossRefPubMed
15.
Zurück zum Zitat Nowicki ER, Birkmeyer NJ, Weintraub RW, Leavitt BJ, Sanders JH, Dacey LJ, Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg. 2007;83:921–9.CrossRef Nowicki ER, Birkmeyer NJ, Weintraub RW, Leavitt BJ, Sanders JH, Dacey LJ, Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg. 2007;83:921–9.CrossRef
16.
Zurück zum Zitat Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, et al; EurpSCORE Project Group. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg. 2002;22:101–5.CrossRefPubMed Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL, et al; EurpSCORE Project Group. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg. 2002;22:101–5.CrossRefPubMed
17.
Zurück zum Zitat Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008;1:167–175.CrossRefPubMed Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008;1:167–175.CrossRefPubMed
18.
Zurück zum Zitat Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009–3016.CrossRefPubMed Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009–3016.CrossRefPubMed
19.
Zurück zum Zitat Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080–1090.CrossRefPubMed Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080–1090.CrossRefPubMed
20.
Zurück zum Zitat Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62–69.CrossRefPubMed Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62–69.CrossRefPubMed
21.
Zurück zum Zitat Tamburino C, Capodanno D, Mule M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia G. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol. 2009;21:93–98.PubMed Tamburino C, Capodanno D, Mule M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia G. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol. 2009;21:93–98.PubMed
22.
Zurück zum Zitat Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242–249.CrossRefPubMed Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242–249.CrossRefPubMed
23.
Zurück zum Zitat •• O’Brien SM, Shahian DM, Filardo G, et al, for the Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg 2009; 88(Suppl):23–42. This is a detailed summary of the STS-PROM risk model for isolated valve surgery. •• O’Brien SM, Shahian DM, Filardo G, et al, for the Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg 2009; 88(Suppl):23–42. This is a detailed summary of the STS-PROM risk model for isolated valve surgery.
24.
Zurück zum Zitat Shahian DM, O’Brien SM, Filardo G, et al, for the Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3—valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88(Suppl):43–62.CrossRef Shahian DM, O’Brien SM, Filardo G, et al, for the Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3—valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88(Suppl):43–62.CrossRef
25.
Zurück zum Zitat Collart F, Feier H, Kerbaul F, Mouly-Bandini A, Riberi A, Mesana TG, et al. Valvular surgery in octogenarians: operative risk factors, evaluation of EuroSCORE and long term results. Eur J Cardiothorac Surg. 2005;27:276–80.CrossRefPubMed Collart F, Feier H, Kerbaul F, Mouly-Bandini A, Riberi A, Mesana TG, et al. Valvular surgery in octogenarians: operative risk factors, evaluation of EuroSCORE and long term results. Eur J Cardiothorac Surg. 2005;27:276–80.CrossRefPubMed
26.
Zurück zum Zitat • Brown ML, Schaff HV, Sarano ME, Li Z, Sundt TM, Dearani JA, Mullany CJ, Orszulak TA. Is the European system for cardiac operative risk evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg 2008;136:566–71. This is a clear demonstration of the inadequacy of the LES risk algorithm with increasing risk in surgical AVR. CrossRefPubMed • Brown ML, Schaff HV, Sarano ME, Li Z, Sundt TM, Dearani JA, Mullany CJ, Orszulak TA. Is the European system for cardiac operative risk evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg 2008;136:566–71. This is a clear demonstration of the inadequacy of the LES risk algorithm with increasing risk in surgical AVR. CrossRefPubMed
27.
Zurück zum Zitat Leontyev S, Walther T, Borger M, Lehmann S, Funkat AK, Rastan A, Kempfert J, Falk V, Mohr FW. Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg 2009;87: 1440–5.CrossRefPubMed Leontyev S, Walther T, Borger M, Lehmann S, Funkat AK, Rastan A, Kempfert J, Falk V, Mohr FW. Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg 2009;87: 1440–5.CrossRefPubMed
28.
Zurück zum Zitat Osswald BR, Gegouskov V, Badowski-Zyla D, Tochtermann U, Thomas G, Hagl S, Blackstone EH. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009;30(1):74–80.CrossRefPubMed Osswald BR, Gegouskov V, Badowski-Zyla D, Tochtermann U, Thomas G, Hagl S, Blackstone EH. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009;30(1):74–80.CrossRefPubMed
29.
Zurück zum Zitat • Dewey TM, Brown DB, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180–7. This retrospective review of the highest-risk patients undergoing surgical AVR demonstrates the overprediction of risk by the LES and the underprediction by the STS-PROM. CrossRefPubMed • Dewey TM, Brown DB, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180–7. This retrospective review of the highest-risk patients undergoing surgical AVR demonstrates the overprediction of risk by the LES and the underprediction by the STS-PROM. CrossRefPubMed
30.
Zurück zum Zitat Wendt D, Osswald BR, Kayser K, Thielmann, M, Tossios P, Massoudy P, Kamler M, Jakob H. Society of Thoracic Surgeons Score Is Superior to the EuroSCORE Determining Mortality in High Risk Patients Undergoing Isolated Aortic Valve Replacement Ann. Thorac. Surg., August 2009; 88: 468–475CrossRef Wendt D, Osswald BR, Kayser K, Thielmann, M, Tossios P, Massoudy P, Kamler M, Jakob H. Society of Thoracic Surgeons Score Is Superior to the EuroSCORE Determining Mortality in High Risk Patients Undergoing Isolated Aortic Valve Replacement Ann. Thorac. Surg., August 2009; 88: 468–475CrossRef
31.
Zurück zum Zitat Kalavrouziotis D, Li D, Buth KJ Légaré JF: The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study Journal of Cardiothoracic Surgery 2009, 4:32 doi:10.1186/1749-8090-4-32 Kalavrouziotis D, Li D, Buth KJ Légaré JF: The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study Journal of Cardiothoracic Surgery 2009, 4:32 doi:10.​1186/​1749-8090-4-32
32.
Zurück zum Zitat Ranucci M, Castelvecchio S, Menicanti L, Scolleta S, Biagioli B, Giomarelli P. An adjusted EuroSCORE model for high-risk patients. Eur J Cardiothorac Surg 2009;36:791–8.CrossRefPubMed Ranucci M, Castelvecchio S, Menicanti L, Scolleta S, Biagioli B, Giomarelli P. An adjusted EuroSCORE model for high-risk patients. Eur J Cardiothorac Surg 2009;36:791–8.CrossRefPubMed
33.
Zurück zum Zitat Dewey TM, Herbert MA Predicting operative risk: a worthy task—an elusive goal Eur. J. Cardiothorac. Surg., November 2009; 36: 797–798CrossRef Dewey TM, Herbert MA Predicting operative risk: a worthy task—an elusive goal Eur. J. Cardiothorac. Surg., November 2009; 36: 797–798CrossRef
34.
Zurück zum Zitat Coeytaux RM, Williams JW, Gray RN, Wang A Percutaneous Heart Valve Replacement for Aortic Stenosis: State of the Evidence Ann Intern Med September 7, 2010 153:314–324. Coeytaux RM, Williams JW, Gray RN, Wang A Percutaneous Heart Valve Replacement for Aortic Stenosis: State of the Evidence Ann Intern Med September 7, 2010 153:314–324.
Metadaten
Titel
Risk Scores for Predicting Outcomes in Valvular Heart Disease: How Useful?
verfasst von
Michael J. Mack
Publikationsdatum
01.04.2011
Verlag
Current Science Inc.
Erschienen in
Current Cardiology Reports / Ausgabe 2/2011
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-010-0167-9

Weitere Artikel der Ausgabe 2/2011

Current Cardiology Reports 2/2011 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.